Navigation Links
Marc Travel Awards announced for the 2012 Biomedical Engineering Society Annual Meeting
Date:9/20/2012

Bethesda, MD FASEB MARC (Minority Access to Research Careers) Program has announced the travel award recipients for the 2012 Biomedical Engineering Society (BMES) Annual Meeting in Atlanta, GA from October 24-27, 2012. These awards are meant to promote the entry of underrepresented minority students, postdoctorates and scientists into the mainstream of the basic science community and to encourage the participation of young scientists at the 2012 BMES Annual Meeting.

Awards are given to poster/platform presenters and faculty mentors paired with the students/trainees they mentor. This year MARC conferred 12 awards totaling $22,200.

The FASEB MARC Program is funded by a grant from the National Institute of General Medical Sciences, National Institutes of Health. A primary goal of the MARC Program is to increase the number and competitiveness of underrepresented minorities engaged in biomedical and behavioral research.


'/>"/>

Contact: Gail Pinder
gpinder@faseb.org
301-634-7021
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. MARC travel awards announced for 2012 American Society for Bone & Mineral Research annual meeting
2. MARC travel awards announced for the 2012 APS Integrative Biology of Exercise meeting
3. MARC travel awards announced for the 2012 SACNAS Annual Meeting
4. Bigger creatures live longer, travel farther for a reason
5. MARC travel awards announced for 2012 Institute on Teaching and Mentoring
6. MARC travel awards announced for Leadership Development and Grant Writing Seminar
7. MARC travel awards announced for the 2012 ECCB/ISCB Conference
8. MARC travel awards announced for the 2012 American Society of Human Genetics Annual Meeting
9. Frequent traveller: Dysentery-causing bacteria spreading from Europe to Australia
10. MARC travel awards announced for the 2012 Society for the Study of Reproduction 45th Annual Meeting
11. MARC Travel Awards announced for 2012 XXXI Congress of the Societa Italiana di Pathologia e Medicina
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2015)... , May 19, 2015 ... announced the addition of the  "Genetic Testing ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, ... in-depth analysis of the current and future ... gene-based tests, their working principles and types ...
(Date:5/14/2015)... and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) has announced ... Smart Mobile Devices " report to their offering. ... watershed year for fingerprint sensors in smartphones and tablets, ... fingerprint sensors a raison d,etre in the mobile milieu ... must-have feature in flagship smartphones. The key ...
(Date:5/11/2015)... , May 11, 2015  Synaptics Incorporated (NASDAQ: ... interface solutions, today announced the appointment of ... Chief Financial Officer, reporting to Rick Bergman ... current Chief Financial Officer, Kathleen Bayless , ... Mr. Ali brings extensive financial management ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
... among historians, journalists and politicians, and has been recounted everywhere ... British forces used chemical weapons on Iraqis just after World ... fully squared with the historical record, says R. M. Douglas, ... in the December issue of The Journal of Modern ...
... CHAMPAIGN, Ill. Researchers report that a single-stranded DNA-binding protein ... many molecules that interact with DNA, actually moves back and ... recombine or replicate the strands. Their study, of SSB ... the journal Nature . Whenever the double helix ...
... This release is available in French . ... better than men at distinguishing between emotions, especially fear and ... version of the journal Neuropsychologia . As part of ... de Montral Centre de recherche en neuropsychologie et cognition (CERNEC) ...
Cached Biology News:Despite claims, UK did not gas Iraqis in the 1920s, new research finds 2Despite claims, UK did not gas Iraqis in the 1920s, new research finds 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 4Single-stranded DNA-binding protein is dynamic, critical to DNA repair 2Women outperform men when identifying emotions 2Women outperform men when identifying emotions 3
(Date:5/21/2015)... ANGELES , May 21, 2015  CytRx ... and development company specializing in oncology, today announced ... clinical trial with aldoxorubicin for the treatment of ... brain cancer.  The open-label, multisite trial is designed ... aldoxorubicin in patients whose tumors have progressed following ...
(Date:5/21/2015)... Kingston, Ontario (PRWEB) May 21, 2015 ... entered into an exclusive North American distribution agreement ... microbiology testing system. , With more than 160 ... of products and services for laboratory and production ... choice, operational excellence and differentiated services to enable ...
(Date:5/20/2015)... This year has been one of ... US Patented Pearl’s Premium Ultra Low Maintenance Lawn Seed ... that are coming out of record bad weather. ... major global concerns related to water, health, and climate ... alternative to the standard, water-wasting, chemical-treated standard lawn. ...
(Date:5/20/2015)... 2015  Health eCareers, the healthcare industry,s online ... job seekers looking for the flexibility of short-term ... and online tool dedicated exclusively to temporary and ... SHIFT enables employers to quickly find and hire ... diem and other temporary positions, eliminating the time ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 3
... Vaccinogen, Inc. announced that,its new vaccine to ... in Europe starting June 2008., "This makes ... cancer," said Dr. Michael G. Hanna, Jr., Ph.D., ... of our worldwide strategy of profitable,distribution. Questions of ...
... Feb. 27 Pharmasset, Inc.,(Nasdaq: VRUS ) ... SIGnificant Investment Options in Healthcare Conference being,held March ... York, NY. Schaefer Price,Pharmasset,s Chief Executive Officer, will ... 5, 2008 from 2:00 PM to 2:30 PM ...
... CHARLESTON, S.C., Feb. 27 JSJ Pharmaceuticals ... new aesthetic division,Vitivia(TM). Vitivia(TM) will focus on ... of JSJ Pharmaceuticals in the development of,science-based, ... will be its Pro:Vitamin line.,Topical vitamins have ...
Cached Biology Technology:Vaccinogen's New Anti-Cancer Vaccine Commercially Available in Europe This Year 2Pharmasset to Present at Susquehanna's Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5th 2JSJ Pharmaceuticals Announces Launch of Aesthetic Division - Vitivia(TM) 2
Mouse monoclonal [0.N.305] to G protein alpha - BSA and Azide free ( Abpromise for all tested applications). Antigen: Partially purified G protein alpha from rat brain. Entrez GeneID: 2778 ...
Rabbit polyclonal to VEGF Receptor 2 (phospho Y1214) ( Abpromise for all tested applications). entrezGeneID: 3791 SwissProtID: P35968...
...
Guanine nucleotide-binding protein G(k), alpha subunit...
Biology Products: